The NHS will now fund stem cell transplants for adult thalassaemia patients, offering a potential cure and an alternative to lifelong blood transfusions. Previously limited to children due to complications, the treatment is now recommended for eligible patients over 18. Over 600 UK adults with transfusion-dependent thalassaemia could benefit, aiming to reduce health inequalities and improve quality of life. Personal accounts emphasise the transformative impact of the procedure.
How do you feel about the NHS decision to fund stem cell transplants for adult thalassaemia patients, potentially offering a cure and an alternative to lifelong blood transfusions?